Efficacy and Safety of Bempedoic Acid for Prevention of Adverse Cardiovascular Events and Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Efficacy and Safety of Bempedoic Acid for Prevention of Adverse Cardiovascular Events and Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Published:2024-08-09 Issue:5 Volume:31 Page:e566-e572
ISSN:1075-2765
Container-title:American Journal of Therapeutics
language:en
Short-container-title:

Author:

Yasmin Farah¹,Najeeb Hala²,Moeed Abdul²,Ali Eman²,Umar Muhammad³,Ullah Irfan⁴,Shah Nishant⁵,Alraies M. Chadi⁶

Affiliation:

1. Yale University School of Medicine, New Haven, CT

2. Dow University of Health Sciences, Karachi, Pakistan

3. I.U. Health Ball Memorial Hospital, Muncie, IN

4. Kabir Medical College, Gandhara University, Peshawar, Pakistan

5. Duke University School of Medicine, Durham, NC

6. Detroit Medical Center, Cardiovascular Institute, Detroit, MI

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference28 articles.

1. Effect of change in total cholesterol levels on cardiovascular disease among young adults;Jeong;J Am Heart Assoc,2018

2. Network meta‐analysis of randomized trials evaluating the comparative efficacy of lipid‐lowering therapies added to maximally tolerated statins for the reduction of low‐density lipoprotein cholesterol;Toth;J Am Heart Assoc,2022

3. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel;Ference;Eur Heart J,2017

4. Statin intolerance and risk of coronary Heart events and all-cause mortality following myocardial infarction;Serban;J Am Coll Cardiol,2017

5. Bempedoic acid and its role in contemporary management of hyperlipidemia in atherosclerosis;Tummala;Ann Med,2022